Images

<p class="p1"><b>Retatrutide (LY-3437943) — Triple-Agonist Research Peptide</b></p> <p class="p3">Push metabolic-disease investigation forward with Retatrutide, the once-weekly synthetic peptide that co-activates GLP-1, GIP and glucagon receptors. In Phase 2 studies, participants lost up to <span class="s1"><b>24 % of body weight after 48 weeks</b></span>, positioning Retatrutide at the forefront of next-generation obesity and T2D therapeutics.</p> <ul> <li> <p class="p1"><span class="s1"><b>Purity:</b></span> &gt; 99 % (HPLC)</p> </li> <li> <p class="p1"><b>Molecular Weight:</b><span class="s1"> ≈ 4.8 kDa</span></p> </li> <li> <p class="p1"><span class="s1"><b>Form &amp; Sizes:</b></span> Lyophilized powder in <span class="s1"><b>10 mg</b></span> and <span class="s1"><b>30 mg</b></span> research-grade vials</p> </li> <li> <p class="p1"><span class="s1"><b>Solubility:</b></span> Sterile water or 0.6 % saline</p> </li> <li> <p class="p1"><span class="s1"><b>Storage:</b></span> −20 °C long-term; aliquoted reconstitutions ≤ −80 °C</p> </li> </ul> <p><i>For laboratory research use only. Not for human administration.</i><i></i></p>

COA transparency

Certificates of Analysis are batch specific

We obtain Certificates of Analysis (COAs) for each batch. The store may have multiple batches of the same product on hand at once, so there is not a single COA displayed on the product page.

No active batches available.

Have a lot number? Look up your COA.

Research use only

Retatrutide

Product information

10mg

$99.00

Product options

10mg
$99.00
30mg
$249.00
Coming soon, pending lab results for this batch.

Notify me

Sign in to get notified

Product notes

Retatrutide (LY-3437943) — Triple-Agonist Research Peptide

Push metabolic-disease investigation forward with Retatrutide, the once-weekly synthetic peptide that co-activates GLP-1, GIP and glucagon receptors. In Phase 2 studies, participants lost up to 24 % of body weight after 48 weeks, positioning Retatrutide at the forefront of next-generation obesity and T2D therapeutics.

  • Purity: > 99 % (HPLC)

  • Molecular Weight: ≈ 4.8 kDa

  • Form & Sizes: Lyophilized powder in 10 mg and 30 mg research-grade vials

  • Solubility: Sterile water or 0.6 % saline

  • Storage: −20 °C long-term; aliquoted reconstitutions ≤ −80 °C

For laboratory research use only. Not for human administration.